1
|
Bailey-Downs LC, Sherlock LG, Crossley MN, Rivera Negron A, Pierce PT, Wang S, Zhong H, Carter C, Burge K, Eckert JV, Rogers LK, Vitiello PF, Tipple TE. Selenium Deficiency Exacerbates Hyperoxia-Induced Lung Injury in Newborn C3H/HeN Mice. Antioxidants (Basel) 2024; 13:391. [PMID: 38671839 PMCID: PMC11047402 DOI: 10.3390/antiox13040391] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2024] [Revised: 03/09/2024] [Accepted: 03/13/2024] [Indexed: 04/28/2024] Open
Abstract
Extremely preterm infants are often treated with supraphysiological oxygen, which contributes to the development of bronchopulmonary dysplasia (BPD). These same infants exhibit compromised antioxidant capacities due in part to selenium (Se) deficiency. Se is essential for basal and inducible antioxidant responses. The present study utilized a perinatal Se deficiency (SeD) mouse model to identify the combined effects of newborn hyperoxia exposure and SeD on alveolarization and antioxidant responses, including the identification of affected developmental pathways. Se-sufficient (SeS) and SeD C3H/HeN breeding pairs were generated, and pups were exposed to room air or 85% O2 from birth to 14 d. Survival, antioxidant protein expression, and RNA seq analyses were performed. Greater than 40% mortality was observed in hyperoxia-exposed SeD pups. Surviving SeD pups had greater lung growth deficits than hyperoxia-exposed SeS pups. Gpx2 and 4 protein and Gpx activity were significantly decreased in SeD pups. Nrf2-regulated proteins, Nqo1 and Gclc were increased in SeD pups exposed to hyperoxia. RNA seq revealed significant decreases in the Wnt/β-catenin and Notch pathways. Se is a biologically relevant modulator of perinatal lung development and antioxidant responses, especially in the context of hyperoxia exposure. The RNA seq analyses suggest pathways essential for normal lung development are dysregulated by Se deficiency.
Collapse
Affiliation(s)
- Lora C. Bailey-Downs
- University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA; (L.C.B.-D.); (S.W.); (H.Z.); (C.C.); (K.B.); (L.K.R.); (P.F.V.)
| | - Laura G. Sherlock
- University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA;
| | - Michaela N. Crossley
- University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA; (L.C.B.-D.); (S.W.); (H.Z.); (C.C.); (K.B.); (L.K.R.); (P.F.V.)
| | - Aristides Rivera Negron
- University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA; (L.C.B.-D.); (S.W.); (H.Z.); (C.C.); (K.B.); (L.K.R.); (P.F.V.)
| | - Paul T. Pierce
- University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA; (L.C.B.-D.); (S.W.); (H.Z.); (C.C.); (K.B.); (L.K.R.); (P.F.V.)
| | - Shirley Wang
- University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA; (L.C.B.-D.); (S.W.); (H.Z.); (C.C.); (K.B.); (L.K.R.); (P.F.V.)
| | - Hua Zhong
- University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA; (L.C.B.-D.); (S.W.); (H.Z.); (C.C.); (K.B.); (L.K.R.); (P.F.V.)
| | - Cynthia Carter
- University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA; (L.C.B.-D.); (S.W.); (H.Z.); (C.C.); (K.B.); (L.K.R.); (P.F.V.)
| | - Kathryn Burge
- University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA; (L.C.B.-D.); (S.W.); (H.Z.); (C.C.); (K.B.); (L.K.R.); (P.F.V.)
| | - Jeffrey V. Eckert
- University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA; (L.C.B.-D.); (S.W.); (H.Z.); (C.C.); (K.B.); (L.K.R.); (P.F.V.)
| | - Lynette K. Rogers
- University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA; (L.C.B.-D.); (S.W.); (H.Z.); (C.C.); (K.B.); (L.K.R.); (P.F.V.)
| | - Peter F. Vitiello
- University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA; (L.C.B.-D.); (S.W.); (H.Z.); (C.C.); (K.B.); (L.K.R.); (P.F.V.)
| | - Trent E. Tipple
- University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA; (L.C.B.-D.); (S.W.); (H.Z.); (C.C.); (K.B.); (L.K.R.); (P.F.V.)
- Oklahoma Children’s Hospital OU Health, Oklahoma City, OK 73104, USA
| |
Collapse
|
2
|
Vresk L, Flanagan M, Daniel AI, Potani I, Bourdon C, Spiegel-Feld C, Thind MK, Farooqui A, Ling C, Miraglia E, Hu G, Wen B, Zlotkin S, James P, McGrath M, Bandsma RHJ. Micronutrient status in children aged 6-59 months with severe wasting and/or nutritional edema: implications for nutritional rehabilitation formulations. Nutr Rev 2024:nuad165. [PMID: 38350491 DOI: 10.1093/nutrit/nuad165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/15/2024] Open
Abstract
Undernutrition remains a global struggle and is associated with almost 45% of deaths in children younger than 5 years. Despite advances in management of severe wasting (though less so for nutritional edema), full and sustained recovery remains elusive. Children with severe wasting and/or nutritional edema (also commonly referred to as severe acute malnutrition and part of the umbrella term "severe malnutrition") continue to have a high mortality rate. This suggests a likely multifactorial etiology that may include micronutrient deficiency. Micronutrients are currently provided in therapeutic foods at levels based on expert opinion, with few supportive studies of high quality having been conducted. This narrative review looks at the knowledge base on micronutrient deficiencies in children aged 6-59 months who have severe wasting and/or nutritional edema, in addition to highlighting areas where further research is warranted (See "Future Directions" section).
Collapse
Affiliation(s)
- Laura Vresk
- Translational Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada
| | - Mary Flanagan
- Translational Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada
| | - Allison I Daniel
- Translational Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada
- Department of Nutritional Sciences, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
| | - Isabel Potani
- Translational Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada
| | - Celine Bourdon
- Translational Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada
| | - Carolyn Spiegel-Feld
- Translational Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada
| | - Mehakpreet K Thind
- Translational Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada
| | - Amber Farooqui
- Translational Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada
| | - Catriona Ling
- Translational Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada
| | - Emiliano Miraglia
- Translational Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada
| | - Guanlan Hu
- Translational Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada
| | - Bijun Wen
- Translational Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada
| | - Stanley Zlotkin
- Department of Nutritional Sciences, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
| | - Philip James
- Emergency Nutrition Network, Oxford, United Kingdom
| | | | - Robert H J Bandsma
- Translational Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada
- Department of Nutritional Sciences, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
| |
Collapse
|
3
|
Minich WB. Selenium Metabolism and Biosynthesis of Selenoproteins in the Human Body. BIOCHEMISTRY. BIOKHIMIIA 2022; 87:S168-S102. [PMID: 35501994 PMCID: PMC8802287 DOI: 10.1134/s0006297922140139] [Citation(s) in RCA: 45] [Impact Index Per Article: 22.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/30/2021] [Revised: 10/04/2021] [Accepted: 10/05/2021] [Indexed: 12/13/2022]
Abstract
As an essential trace element, selenium (Se) plays a tremendous role in the functioning of the human organism being used for the biosynthesis of selenoproteins (proteins containing one or several selenocysteine residues). The functions of human selenoproteins in vivo are extremely diverse. Many selenoproteins have an antioxidant activity and, hence, play a key role in cell antioxidant defense and maintenance of redox homeostasis, which accounts for their involvement in diverse biological processes, such as signal transduction, proliferation, cell transformation and aging, ferroptosis, immune system functioning, etc. One of the critical functions of selenoenzymes is participation in the synthesis of thyroid hormones regulating basal metabolism in all body tissues. Over the last decades, optimization of population Se intake for prevention of diseases related to Se deficiency or excess has been recognized as a pressing issue in modern healthcare worldwide.
Collapse
Affiliation(s)
- Waldemar B Minich
- Institute of Experimental Endocrinology, Charite, Medical University, Berlin, D-10115, Germany.
| |
Collapse
|
4
|
Lee JY, Shin HJ, Bae HJ, Jo YH, Cho YS, Shin SH, Kim EK, Kim HS. Effect of selenium-free parenteral nutrition on serum selenium of neonates and infants maintained on long-term parenteral nutrition. JPEN J Parenter Enteral Nutr 2021; 46:1045-1053. [PMID: 34665472 DOI: 10.1002/jpen.2281] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2021] [Revised: 09/27/2021] [Accepted: 10/12/2021] [Indexed: 11/11/2022]
Abstract
BACKGROUND The risk of selenium deficiency increases for infants receiving long-term parenteral nutrition (PN). This study analyzed selenium deficiency in neonates and infants requiring long-term PN and evaluated the effect of intravenous (IV) selenium provision. METHODS This study was a retrospective study of neonates and infants who were admitted to a neonatal intensive care unit from January 2010 to December 2019, received PN for ≥2 weeks, and had their serum selenium concentration measured. Patients were divided into two groups, depending on their serum selenium concentration, a deficient group (n = 55) and a nondeficient group (n = 47). RESULTS Of the study participants, 53.9% (55 of 102) were deficient in selenium. No difference in demographic and clinical characteristics existed except bronchopulmonary dysplasia. A subgroup analysis was performed for patients (n = 29). The average dose of IV selenium administered to patients was 2.7 ± 1.0 mcg/kg/day. The average initial serum selenium concentration was 36.5 ± 18.0 mcg/L, and the serum concentration significantly increased to 52.5 ± 19.1 mcg/L after IV selenium administration (P < .001). The correlation between the average IV selenium dose and the change in serum selenium concentrations was statistically significant (r = .423; P = .022). CONCLUSION Selenium deficiency is common in neonates and infants receiving long-term PN. Serum selenium concentration increased proportionally as the IV selenium dose increased. Therefore, it is recommended to supply a proper dose of IV selenium depending on the degree of selenium deficiency.
Collapse
Affiliation(s)
- Ji Young Lee
- Department of Pharmacy, Seoul National University Hospital, Jongno-gu, Seoul, Republic of Korea
| | - Hyun Jung Shin
- Department of Pharmacy, Seoul National University Hospital, Jongno-gu, Seoul, Republic of Korea
| | - Hye Jung Bae
- Department of Pharmacy, Seoul National University Hospital, Jongno-gu, Seoul, Republic of Korea
| | - Yun Hee Jo
- Department of Pharmacy, Seoul National University Hospital, Jongno-gu, Seoul, Republic of Korea
| | - Yoon Sook Cho
- Department of Pharmacy, Seoul National University Hospital, Jongno-gu, Seoul, Republic of Korea
| | - Seung Han Shin
- Department of Pediatrics, Seoul National University Children's Hospital, Jongno-gu, Seoul, Republic of Korea
| | - Ee-Kyung Kim
- Department of Pediatrics, Seoul National University Children's Hospital, Jongno-gu, Seoul, Republic of Korea
| | - Han-Suk Kim
- Department of Pediatrics, Seoul National University Children's Hospital, Jongno-gu, Seoul, Republic of Korea
| |
Collapse
|